Macroautophagy in lymphatic endothelial cells inhibits T cell-mediated autoimmunity.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
07 06 2021
Historique:
received: 18 08 2020
revised: 21 12 2020
accepted: 05 02 2021
entrez: 16 4 2021
pubmed: 17 4 2021
medline: 2 10 2021
Statut: ppublish

Résumé

Lymphatic endothelial cells (LECs) present peripheral tissue antigens to induce T cell tolerance. In addition, LECs are the main source of sphingosine-1-phosphate (S1P), promoting naive T cell survival and effector T cell exit from lymph nodes (LNs). Autophagy is a physiological process essential for cellular homeostasis. We investigated whether autophagy in LECs modulates T cell activation in experimental arthritis. Whereas genetic abrogation of autophagy in LECs does not alter immune homeostasis, it induces alterations of the regulatory T cell (T reg cell) population in LNs from arthritic mice, which might be linked to MHCII-mediated antigen presentation by LECs. Furthermore, inflammation-induced autophagy in LECs promotes the degradation of Sphingosine kinase 1 (SphK1), resulting in decreased S1P production. Consequently, in arthritic mice lacking autophagy in LECs, pathogenic Th17 cell migration toward LEC-derived S1P gradients and egress from LNs are enhanced, as well as infiltration of inflamed joints, resulting in exacerbated arthritis. Our results highlight the autophagy pathway as an important regulator of LEC immunomodulatory functions in inflammatory conditions.

Identifiants

pubmed: 33861848
pii: 212000
doi: 10.1084/jem.20201776
pmc: PMC8056750
pii:
doi:

Substances chimiques

Lysophospholipids 0
sphingosine 1-phosphate 26993-30-6
Sphingosine NGZ37HRE42

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2021 Harlé et al.

Déclaration de conflit d'intérêts

Disclosures: The authors declare no competing interests exist.

Références

Cell Rep. 2020 Mar 24;30(12):4110-4123.e4
pubmed: 32209472
Eur Cytokine Netw. 2006 Sep;17(3):202-10
pubmed: 17194641
Nat Commun. 2020 Jan 27;11(1):538
pubmed: 31988323
Autophagy. 2009 May;5(4):576-7
pubmed: 19333005
Annu Rev Immunol. 2009;27:423-49
pubmed: 19105657
J Rheumatol. 2000 Jan;27(1):58-63
pubmed: 10648018
J Lipid Res. 2010 Sep;51(9):2546-59
pubmed: 20386061
J Exp Med. 2010 Apr 12;207(4):689-97
pubmed: 20308362
Mucosal Immunol. 2016 Mar;9(2):444-57
pubmed: 26307665
Autophagy. 2014 May;10(5):913-25
pubmed: 24589857
Eur J Immunol. 2015 Oct;45(10):2721-9
pubmed: 26278423
FASEB J. 2012 Jul;26(7):2835-46
pubmed: 22459150
Exp Mol Med. 2012 Nov 30;44(11):694-705
pubmed: 23114425
Immunol Cell Biol. 1998 Feb;76(1):34-40
pubmed: 9553774
Clin Immunol. 2010 Aug;136(2):197-204
pubmed: 20421177
Immunity. 2018 May 15;48(5):1014-1028.e6
pubmed: 29752062
Bioinformatics. 2009 Jun 1;25(11):1463-5
pubmed: 19346324
Blood. 2010 Jan 28;115(4):906-9
pubmed: 19965622
Front Immunol. 2018 Nov 29;9:2777
pubmed: 30555468
Oncotarget. 2017 Jul 24;8(39):65588-65600
pubmed: 29029455
J Immunol. 2009 Aug 1;183(3):2097-103
pubmed: 19596980
J Immunol. 2007 Jun 1;178(11):6806-13
pubmed: 17513728
Biomed Res Int. 2014;2014:698313
pubmed: 24524085
J Clin Invest. 2017 Jun 30;127(7):2789-2804
pubmed: 28581446
Nat Protoc. 2008;3(4):612-8
pubmed: 18388943
J Exp Med. 2014 Jun 2;211(6):1153-66
pubmed: 24842370
Immunology. 2011 Jun;133(2):257-69
pubmed: 21426341
Front Immunol. 2015 May 19;6:252
pubmed: 26042127
Nat Immunol. 2003 Apr;4(4):330-6
pubmed: 12612578
Immunol Rev. 2014 May;259(1):23-39
pubmed: 24712457
Elife. 2014 Nov 19;3:
pubmed: 25407678
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1903-8
pubmed: 19174509
Traffic. 2009 Jun;10(6):615-20
pubmed: 19192248
Cell Rep. 2015 Mar 17;10(10):1708-1721
pubmed: 25772358
New Phytol. 2019 Aug;223(3):1461-1477
pubmed: 31077612
J Mol Graph Model. 2008 Jun;26(8):1189-201
pubmed: 18165127
J Immunol. 2007 Jul 15;179(2):993-1003
pubmed: 17617591
Cell Res. 2014 Jan;24(1):24-41
pubmed: 24366339
Autophagy. 2016;12(1):1-222
pubmed: 26799652
Science. 2008 Aug 8;321(5890):843-7
pubmed: 18687966
Nature. 2006 Jun 15;441(7095):885-9
pubmed: 16625204
Methods. 2017 Feb 15;115:28-41
pubmed: 28057586
Nature. 2009 Apr 30;458(7242):1131-5
pubmed: 19339967
J Exp Med. 2010 Jan 18;207(1):17-27
pubmed: 20026661
Cell Rep. 2019 Jul 2;28(1):21-29.e6
pubmed: 31269441
FASEB J. 2015 Dec;29(12):5018-28
pubmed: 26324848
Cell Rep. 2012 Nov 29;2(5):1104-10
pubmed: 23103166
Nature. 2017 Jun 1;546(7656):158-161
pubmed: 28538737
Nat Commun. 2014 Jun 06;5:3989
pubmed: 24905362
Front Oncol. 2017 Mar 31;7:51
pubmed: 28409123
J Exp Med. 2010 Apr 12;207(4):681-8
pubmed: 20308365
J Clin Invest. 2011 Aug;121(8):2984-92
pubmed: 21765212
Gastroenterology. 2008 Apr;134(4):1028-37
pubmed: 18395084
Inflammation. 2018 Mar;41(2):485-495
pubmed: 29181736
J Immunol. 2005 May 1;174(9):5444-55
pubmed: 15845457
Nat Commun. 2015 Apr 10;6:6771
pubmed: 25857745
Autophagy. 2017 May 4;13(5):885-899
pubmed: 28521611
Immunity. 2012 Feb 24;36(2):262-75
pubmed: 22326580
Mol Biol Cell. 2004 Mar;15(3):1101-11
pubmed: 14699058
J Exp Med. 2018 Jan 2;215(1):35-49
pubmed: 29242199
Biol Pharm Bull. 2013;36(11):1739-46
pubmed: 23995704
J Biol Chem. 2014 Sep 19;289(38):26525-26532
pubmed: 25077962
N Engl J Med. 2006 Sep 14;355(11):1124-40
pubmed: 16971719
Nat Med. 2010 Dec;16(12):1421-8
pubmed: 21102457
Life Sci Alliance. 2018 Dec 17;1(6):e201800164
pubmed: 30584641
Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16069-74
pubmed: 12446836
Curr Opin Cell Biol. 2000 Oct;12(5):563-8
pubmed: 10978890
Nat Immunol. 2007 Feb;8(2):181-90
pubmed: 17195844
Nat Immunol. 2009 Sep;10(9):1026-33
pubmed: 19668219
PLoS Biol. 2020 Apr 6;18(4):e3000704
pubmed: 32251437
Cell Rep. 2016 May 3;15(5):1076-1087
pubmed: 27117419
Nat Immunol. 2012 Apr 01;13(5):499-510
pubmed: 22466668
J Immunol. 2014 Jun 1;192(11):5002-11
pubmed: 24795456
Front Immunol. 2018 Oct 17;9:2334
pubmed: 30386331
J Lipid Res. 2014 Dec;55(12):2521-31
pubmed: 25332431
J Immunol. 2009 Aug 1;183(3):1767-79
pubmed: 19587009
Immunology. 2014 Jul;142(3):347-53
pubmed: 24597601
J Immunol. 2016 Sep 1;197(5):1708-19
pubmed: 27474075
Biomed Res Int. 2014;2014:832704
pubmed: 25013806
J Exp Med. 2013 Feb 11;210(2):287-300
pubmed: 23382543
Cell Death Differ. 2009 Jul;16(7):991-1005
pubmed: 19229247
Exp Ther Med. 2018 Sep;16(3):1621-1628
pubmed: 30186380
World J Biol Chem. 2010 Dec 26;1(12):362-8
pubmed: 21537471
Nat Immunol. 2011 Sep 18;12(11):1096-104
pubmed: 21926986

Auteurs

Guillaume Harlé (G)

Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.

Camille Kowalski (C)

Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.

Juan Dubrot (J)

Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.

Dale Brighouse (D)

Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.

Gaëlle Clavel (G)

Institut National de la Santé et de la Recherche Médicale, UMR 1125, Université Sorbonne Paris Cité, Université Paris, Paris, France.

Robert Pick (R)

Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.

Natacha Bessis (N)

Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Jennifer Niven (J)

Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.

Christoph Scheiermann (C)

Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.

Monique Gannagé (M)

Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.

Stéphanie Hugues (S)

Department of Pathology and Immunology, School of Medicine, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH